We represent foreign and domestic clients in a broad range of capital raising, M&A and other corporate transactions. Below are tombstone listings of certain of our recent representative transactions. Please click on a tombstone for a description of the specific deal.
DelMar Pharmaceuticals
$7,500,000
Private Placement of Series B Preferred Stock
May 2016
Citius Pharmaceuticals Inc.
Acquisition
April 2016
ContraVir Pharmaceuticals, Inc.
$7,000,000
Public Offering
Common Stock and Warrants
Labstyle Innovations Corp.
$6,000,000
Public Offering
Common Stock and Warrants
Viatar CTC Solutions Inc.
$4,200,000
Private Placement of Convertible Preferred Stock
March 2016
Pershing Gold Corporation
$6,900,000
Private Placement of Common Stock and Warrants
Represented Laidlaw & Company (UK) Ltd. as Placement Agent
Amarantus BioScience Holdings, Inc.
$3,000,000
Convertible Preferred Stock and Warrants
February 2016
OWC Pharmaceutical Research Corp.
$787,500
PIPE
Convertible Note & Common Stock
CBC Biotechnologies Inc.
$2,000,000
Series A Round
December 2015
eMagin
$6,000,000
Registered Direct Offering
Common Stock and Warrants
Takung Art Co.
$1,896,000
PIPE
Common Stock
Genius Brands International
$4,333,000
PIPE
Common Stock & Warrants
Calpian Inc.
$2,135,000
PIPE
Common Stock & Warrants
UQM Technologies
$6,400,000
Registered Direct
Common Stock and Warrants
Oasmia Pharmaceutical AB
$9,500,000
RADSs & Warrants
IPO & U.S. NASDAQ Listing
